Selective removal of the selenocysteine tRNA[Ser]Sec gene (Trsp) in mouse mammary epithelium

Molecular and Cellular Biology

Volumn 23, Issue 5, 2003, Pages 1477-1488

  Kumaraswamy, Easwari ^a,f   Carlson, Bradley A ^a   Morgan, Fanta ^b   Miyoshi, Keiko ^b,g   Robinson, Gertraud W ^b   Su, Dan ^c   Wang, Shulin ^a   Southon, Eileen ^d   Tessarollo, Lino ^d   Lee, Byeong Jae ^e   Gladyshev, Vadim N ^c   Hennighausen, Lothar ^b   Hatfield, Dolph L ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^c UNIVERSITY OF NEBRASKA LINCOLN   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

^e Seoul National University   (South Korea)

^f WISTAR INSTITUTE   (United States)

^g UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; CRE RECOMBINASE; GLUTATHIONE PEROXIDASE; GLUTATHIONE PEROXIDASE 1; PROTEIN; PROTEIN GPX4; PROTEIN P53; SELENOCYSTEINE; SELENOPROTEIN; TRANSFER RNA; UNCLASSIFIED DRUG; WHEY ACIDIC PROTEIN;

ALLELE; AMINOACYLATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BREAST DEVELOPMENT; BREAST EPITHELIUM; CANCER SUSCEPTIBILITY; CHIMERA; CONTROLLED STUDY; DIAGNOSTIC TEST; GENE; GENE BRCA1; GENE DELETION; GENE EXPRESSION; GENE INACTIVATION; GENE LOXP; GENE NEO; GENE TARGETING; GENE TRSP; GENETIC SUSCEPTIBILITY; GENOTYPE; HOMOZYGOSITY; KNOCKOUT MOUSE; LONG TERMINAL REPEAT; MOUSE; NONHUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN ISOLATION; PROTEIN SYNTHESIS; RNA ANALYSIS; TRANSGENE; TRANSGENIC MOUSE;

ALLELES; ANIMALS; BLOTTING, NORTHERN; BLOTTING, WESTERN; BREAST; CHROMATOGRAPHY; CROSSES, GENETIC; EPITHELIUM; GENE DELETION; GENES, BRCA1; GENES, P53; GENETIC VECTORS; GLUTATHIONE PEROXIDASE; HETEROZYGOTE; KIDNEY; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; MODELS, GENETIC; PHENOTYPE; PROMOTER REGIONS (GENETICS); PROTEINS; RECOMBINATION, GENETIC; RNA, TRANSFER, AMINO ACYL; SELENOPROTEINS; TISSUE DISTRIBUTION; TRANSGENES;

ANIMALIA; MOUSE MAMMARY TUMOR VIRUS; MUS MUSCULUS;

EID: 0037372748     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.23.5.1477-1488.2003     Document Type: Article

References (45)

1. Baum, M. K., A. Campa, M. J. Miguez-Burbano, X. Burbano, and G. Shor-Posner. 2001. Role of selenium in HIV/AIDS, p. 247-255. In D. L. Hatfield (ed.), Selenium: its molecular biology and role in human health. Kluwer Academic Publishers, Norwell, Mass.
2. Beck, M. A. 2001. Selenium as an antiviral agent, p. 235-245. In D. L. Hatfield (ed.), Selenium: its molecular biology and role in human health. Kluwer Academic Publishers, Norwell, Mass.
3. Bedell, M. A., N. A. Jenkins, and N. G. Copeland. 1997. Mouse models of human disease. I. Techniques and resources for genetic analysis in mice. Genes Dev. 11:1-10.
4. Betz, U. A., C. A. Vosshenrich, K. Rajewsky, and W. Muller. 1996. Bypass of lethality with mosaic mice generated by Cre-LoxP-mediated recombination. Curr. Biol. 6:1307-1316.
5. Bosl, M. R., K. Takadu, M. Oshima, S. Nishimura, and M. M. Taketo. 1997. Early embryonic lethality caused by targeted disruption of the mouse selenocysteine tRNA gene (Trsp). Proc. Natl. Acad. Sci. USA 94:5531-5534.
6. Chen, Y., W. H. Lee, and H. K. Chew. 1999. Emerging roles of BRCA1 in transcriptional regulation and DNA repair. J. Cell Physiol. 181:385-392.
7. [ser]sec gene. Biochemistry 36:8634-8639.
8. Chittum, H. S., K. E. Hill, B. A. Carlson, B. J. Lee, R. F. Burk, and D. L. Hatfield. 1997. Replenishment of selenium deficient rats with selenium results in redistribution of the selenocysteine tRNA population in a tissue specific manner. Biochim. Biophys. Acta 1359:25-34.
9. Clark, L. C., G. F. Combs Jr., B. W. Turnbull, E. H. Slate, D. K. Chalker, J. Chow, L. S. Davis, R. A. Glover, G. F. Graham, E. G. Gross, A. Krongrad, J. L. Lesher, Jr., H. K. Park, B. B. Sanders, Jr., C. L. Smith, and J. R. Taylor. 1996. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. JAMA 276:1957-1963.
10. Combs, G. R., and L. Liu. 2001. Selenium as a cancer preventative agent, p. 205-217. In D. L. Hatfield (ed.), Selenium: its molecular biology and role in human health. Kluwer Academic Publishers, Norwell, Mass.
11. Coppinger, R. J., and A. M. Diamond. 2001. Selenium deficiency and human disease, p. 219-233. In D. L. Hatfield (ed.), Selenium: its molecular biology and role in human health. Kluwer Academic Publishers, Norwell, Mass.
12. Cui, Y., K. M, Miyoshi, E. Claudio, U. K. Siebenlist, F. J. Gonzalez, J. Flaws, K.-U. Wagner, and L. Hennighausen. 2002. Loss of the peroxisome proliferation-activated receptor gamma (PPARγ) does not affect mammary development and propensity for tumor formation but leads to reduced fertility. J. Biol. Chem. 277:17830-17835.
13. Deng, C.-X., and S. G. Brodie. 2000. Roles of BRCA1 and its interacting proteins. BioEssays 22:728-737.
14. [ser]sec. J. Biol. Chem. 268:14215-14223.
15. Evan, G., and T. Littlewood. 1998. A matter of life and cell death. Science 281:1317-1322.
16. Fletcher, J. E., P. R. Copeland, D. M. Driscoll, and A. Krol. 2001. The selenocysteine incorporation machinery: interactions between the SECIS RNA and the SECIS-binding protein SBP2. RNA 7:1442-1453.
17. Flohe, L., R. Brigelius-Flohe, M. Maiorino, A. Roveri, J. Wissing, and F. Ursini. 2001. Selenium and male reproduction, p. 273-281. In D. L. Hatfield (ed.), Selenium: its molecular biology and role in human health. Kluwer Academic Publishers, Norwell, Mass.
18. Futreal, P. A., Q. Liu, D. Shattuck-Eidens, C. Cochran, K. Harshman, S. Tavtigian, L. M. Bennett, A. Haugen-Strano, J. Swensen, Y. Miki, et al. 1994. BRCA1 mutations in primary breast and ovarian carcinomas. Science 266:120-122.
19. Gladyshev, V. N., K.-T. Jeang, J. C. Wootton, and D. L. Hatfield. 1998. A new human selenium-containing protein. J. Biol. Chem. 273:8910-8915.
20. Gladyshev, V. N., V. M. Factor, F. Housseau, and D. L. Hatfield. 1998. Contrasting patterns of regulation of the antioxidant selenoproteins, thioredoxin reductase, and glutathione peroxidase, in cancer cells. Biochem. Biophys. Res. Commun. 251:488-493.
21. Gladyshev, V. N., T. C. Stadtman, D. L. Hatfield, and K.-T. Jeang. 1999. Levels of major selenoproteins in T cells decrease during HIV infection and low-molecular-mass selenium compounds increase. Proc. Natl. Acad. Sci. USA 96:835-839.
22. Gowen, L. C., B. L. Johnson, A. M. Latour, K. K. Sulik, and B. H. Koller. 1996. Brcal deficiency results in early embryonic lethality characterized by neuroepithelial abnormalities. Nat. Genet. 12:191-194.
23. Gunning, P., T. H. Leavitt, G. Muscat, S. Y. Ng, and L. Kedes. 1987. A human β-actin expression vector system directs high-level accumulation of antisense transcripts. Proc. Natl. Acad. Sci. USA 84:4831-4835.
24. Hatfield, D. L., C. R. Mathews, and M. Rice. 1979. Aminoacyl-transfer RNA populations in mammalian cells: chromatographic profiles and patterns of codon recognition. Biochim. Biophys. Acta 564:414-423.
25. [ser]sec population in mammalian cells. Nucleic acids Res. 19:939-943.
26. Hatfield, D. L., and V. N. Gladyshev. 2002. How selenium has altered our understanding of the genetic code. Mol. Cell. Biol. 22:3565-3576.
27. Kelmers, A. D., and D. E. Heatherly. 1971. Columns for rapid chromatographic separation of small amounts of tracer-labeled transfer ribonucleic acids. Anal. Biochem. 44:486-495.
28. Kwan, K.-M. 2002. Conditional alleles in mice: practical considerations for tissue-specific knockouts. Genesis 32:49-62.
29. Le Provost, F., G. Riedlinger, S. H. Yim, J. Benedict, F. J. Gonzalez, J. Flaws, and L. Hennighausen. 2002. The aryl hydrocarbon receptor (AhR) and its nuclear translocator (Arnt) are dispensable for normal mammary gland development but are required for fertility. Genesis 32:231-239.
30. Low, S. C., and M. J. Berry. 1996. Knowing when not to stop: selenocysteine incorporation in eukaryotes. Trends Biochem. Sci. 21:203-208.
31. Low, S. C., E. Grundner-Culemann, J. W. Harney, and M. J. Berry. 2000. SECIS-SBP2 interactions dictate selenocysteine incorporation efficiency and selenoprotein hierarchy. EMBO J. 19:6882-6890.
32. MacLachlan, T. K., K. Somasundaram, M. Sgagias, Y. Shifman, R. J. Muschel, K. H. Cowan, and W. S. El-Deiry. 2000. BRCA1 effects on the cell cycle and the DNA damage response are linked to altered gene expression. J. Biol. Chem. 275:2777-2785.
33. McKenzie, R. C., T. S. Rafferty, G. J. Beckett, and J. R. Arthur. 2001. Effects of selenium on immunity and aging, p. 257-272. In: D. L. Hatfield (ed.), Selenium: its molecular biology and role in human health. Kluwer Academic Publishers, Norwell, Mass.
34. Miki, Y., J. Swensen, D. Shattuck-Eidens, P. A. Futreal, K. Harshman, S. Tavtigian, Q. Liu, C. Cochran, L. M. Bennett, W. Ding, et al. 1994. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266:66-71.
35. Moos, P. J., K. Edes, P. Cassidy, E. Massuda, and F. A. Fitzpatrick. 2003. Electrophilic prostaglandins and lipid aldehydes repress redox sensitive transcription factors p53 and HIF by impairing the selenoprotein thioredoxin reductase. J. Biol. Chem. 278:745-750.
36. [ser]sec gene. RNA 4:1436-1443.
37. Moustafa, M., B. A. Carlson, M. A. El-Saadani, G. V. Kryukov, Q.-I. Sun, J. W. Harney, K. E. Hill, G. F. Combs, L. Feigenbum, D. B. Mansur, R. F. Burk, M. J. Berry, A. M. Diamond, B. J. Lee, V. N. Gladyshev, and D. L. Hatfield. 2001. Selective inhibition of selenocysteine tRNA maturation and selenoprotein synthesis in transgenic mice expressing isopentenyladenosine-deficient selenocysteine tRNA. Mol. Cell. Biol. 21:3840-3852.
38. Seo, Y. R., M. R. Kelley, and M. L. Smith. Selenomethionine regulation of p53 by a ref1-dependent redox mechanism. Proc. Natl. Acad. Sci. USA 99:14548-14553.
39. Sun, Q.-A., Y. Wu, F. Zappacosta, K.-T. Jeang, B. J. Lee, D. L. Hatfield, and V. N. Gladyshev. 1999. Redox regulation of cell signaling by selenocysteine in mammalian thioredoxin reductases. J. Biol. Chem. 274:24522-24530.
40. Sun, Q.-A., F. Zappacosta, V. M. Factor, P. J. Wirta, D. L. Hatfield, and V. N. Gladyshev. 2001. Heterogeneity within animal thioredoxin reductases. Evidence for alternative first exon splicing. J. Biol. Chem. 276:3106-3114.
41. Venkitaraman, A. R. 2002. Cancer susceptibility and the e functions of BRCA1 and BRCA2. Cell 108:171-182.
42. Wagner, K.-U., R. J. Wall, L. St-Onge, P. Gruss, A. Wynshaw-Boris, L. Garrett, M. Li, P. A. Furth, and L. Hennighausen. 1997. Cre-mediated gene deletion in the mammary gland. Nucleic Acids Res. 25:4323-4330.
43. Wagner, K.-U., K. McAllister, T. Ward, B. Davis, R. Wiseman, and L. Hennighausen. 2001. Spatial and temporal expression of the Cre gene under the control of the MMTV-long terminal repeat in different lines of transgenic mice. Transgenic Res. 10:545-553.
44. Xu, X., K. U. Wagner, D. Larson, Z. Weaver, C. Li, T. Ried, L. Hennighausen, A. Wynshaw-Boris, and C. X. Deng. 1999. Conditional mutation of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation. Nat. Genet. 22:37-43.
45. Zhang, H., K. Somasundaram, Y. Peng, H. Tian, H. Zhang, D. Bi, B. L. Weber, and W. S. El-Deiry. 1998. BRCA1 physically associates with p53 and stimulates its transcriptional activity. Oncogene 16:1713-1721.